Venture Certified
| 연구개발유형 | 2008-11-11 ~ 2010-11-10 | 20080400577 | 2008-11-11 |
| 연구개발유형 | 2015-04-15 ~ 2017-04-14 | 20150400411 | 2008-11-11 |
| 연구개발유형 | 2021-04-21 ~ 2024-04-20 | 20210421020034 | 2008-11-11 |
| 연구개발유형 | 2024-04-21 ~ 2027-04-20 | 20240409020018 | 2008-11-11 |
Revenue CAGR +11.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 152.5B | 160.5B | 122.6B |
| Operating Profit | 24.3B | 16.6B | 13.2B |
| Net Profit | 40.4B | 32.6B | 31.2B |
| Total Assets | 472.2B | 459.4B | 451.3B |
| Total Liabilities | 52.4B | 74.9B | 94.9B |
| Total Equity | 419.8B | 384.4B | 356.4B |
▲ 7.7%
▲ 63.5%
▲ 51.3%
▼ 45.8%
▲ 11.7%
| Name | Position | Role |
|---|---|---|
| 박성민 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청북도 청주시",
"ceo_name": "박성민",
"certificate": [
{
"cert_number": "20080400577",
"changes": "",
"disclosure_date": "2008-11-11",
"first_cert_date": "2008-11-11",
"no": "1",
"type": "연구개발유형",
"valid_period": "2008-11-11 ~ 2010-11-10"
},
{
"cert_number": "20150400411",
"changes": "",
"disclosure_date": "2015-04-15",
"first_cert_date": "2008-11-11",
"no": "2",
"type": "연구개발유형",
"valid_period": "2015-04-15 ~ 2017-04-14"
},
{
"cert_number": "20210421020034",
"changes": "",
"disclosure_date": "2021-04-21",
"first_cert_date": "2008-11-11",
"no": "3",
"type": "연구개발유형",
"valid_period": "2021-04-21 ~ 2024-04-20"
},
{
"cert_number": "20240409020018",
"changes": "",
"disclosure_date": "2024-04-09",
"first_cert_date": "2008-11-11",
"no": "4",
"type": "연구개발유형",
"valid_period": "2024-04-21 ~ 2027-04-20"
}
],
"company_name": "(주) 코씨드 바이오팜",
"corp_no": "150111-*******",
"financials": {
"2022": {
"capital_stock": 159700000,
"cost_of_sales": 3911298000,
"current_assets": 10711533000,
"current_liabilities": 6285787000,
"gross_profit": 8351612000,
"net_income": 3116290000,
"net_income_bs": 2623651000,
"non_current_assets": 34420452000,
"non_current_liabilities": 3203200000,
"non_operating_expenses": 190999000,
"non_operating_income": 1992199000,
"operating_profit": 1315090000,
"revenue": 12262910000,
"sga_expenses": 7036522000,
"total_assets": 45131985000,
"total_equity": 35642998000,
"total_liabilities": 9488987000
},
"2023": {
"capital_stock": 159700000,
"cost_of_sales": 7043265000,
"current_assets": 12294216000,
"current_liabilities": 6592913000,
"gross_profit": 9010777000,
"net_income": 3256583000,
"net_income_bs": 2799399000,
"non_current_assets": 33641094000,
"non_current_liabilities": 900000000,
"non_operating_expenses": 428827000,
"non_operating_income": 2026232000,
"operating_profit": 1659178000,
"revenue": 16054042000,
"sga_expenses": 7351599000,
"total_assets": 45935310000,
"total_equity": 38442397000,
"total_liabilities": 7492913000
},
"2024": {
"capital_stock": 159700000,
"cost_of_sales": 6592673000,
"current_assets": 14560066000,
"current_liabilities": 4331780000,
"gross_profit": 8661461000,
"net_income": 4035178000,
"net_income_bs": 3538006000,
"non_current_assets": 32662118000,
"non_current_liabilities": 910000000,
"non_operating_expenses": 115737000,
"non_operating_income": 1720037000,
"operating_profit": 2430878000,
"revenue": 15254134000,
"sga_expenses": 6230583000,
"total_assets": 47222184000,
"total_equity": 41980404000,
"total_liabilities": 5241780000
}
},
"industry": "화장품 제조업",
"investment": [],
"main_products": "화장품원료",
"phone": "070-5003-****",
"years": [
2024,
2023,
2022
]
}